Worldwide Variability of Antithrombotic Therapy During Cardiac Catheter Ablation in Children: A Survey from 50 Centers Around the World

  • R. BerruecoEmail author
  • G. Sarquella-Brugada
Letter to the Editor

Although electrophysiological studies and cardiac catheter ablation are rare procedures in children, their use has increased during the last decades [1]. These procedures have a thrombotic risk [2]. Guidelines for the prevention of thrombotic events following radiofrequency (RF) catheter ablation are available [1, 3]. However, there is an absence of high-quality evidence in this setting.

A web-based survey regarding prevention and management of thrombotic complications during electrophysiology studies and cardiac catheter ablation procedures in children was designed in order to determine current practice worldwide.

Fifty surveys were returned from 50 centers. Of them, thirty-two had performed more than 20 procedures in children during the previous 3 months. Surveys were filled by pediatric cardiologists (62.5%), cardiologists (24%), and electrophysiologists (12%) from Europe (n = 24) and America (n = 16) mainly. Apart from the results shown in Table 1, it is remarkable that 92% of the...


Compliance with Ethical Standards

Conflict of interest

This article did not receive any funding. Authors do not have any conflict of interest. This article does not contain any studies with human participants performed by any of the authors.


  1. 1.
    Blanc JJ, Almendral J, Brignole M, Fatemi M, Gjesdal K, González-Torrecilla E, Kulakowski P, Lip GY, Shah D, Wolpert C, Scientific Initiatives Committee of the European Heart Rhythm Association (2008) Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. Europace 10:513–527CrossRefGoogle Scholar
  2. 2.
    Kugler JD, Danford DA, Houston KA, Felix G, Pediatric Radiofrequency Ablation Registry of the Pediatric Radiofrequency Ablation Registry of the Pediatric Electrophysiology Society (2002) Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol 13:336–341CrossRefGoogle Scholar
  3. 3.
    Giglia TM, Massicotte MP, Tweddell JS, American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128:2622–2703CrossRefGoogle Scholar
  4. 4.
    Haines DE, Verow AF (1990) Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of the ventricular myocardium. Circulation 82:1034–1038CrossRefGoogle Scholar
  5. 5.
    Calkins H, Prystowsky E, Carlson M et al (1994) Temperature monitoring during radiofrequency catheter ablation procedures using closed loop control. Circulation 90:1279–1286CrossRefGoogle Scholar
  6. 6.
    Zhou L, Keane D, Reed G, Ruskin J (1999) Thromboembolic complications of cardiac RF catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol 10:611–620CrossRefGoogle Scholar
  7. 7.
    Epstein MR, Knapp LD, Martindill M, Lulu JA, Triedman JK, Calkins H, Huang SK, Walsh EP, Saul JP (1996) Embolic complications associated with radiofrequency catheter ablation: Atakr Investigator Group. Am J Cardiol 77:655–658CrossRefGoogle Scholar
  8. 8.
    Moore EF, Pak J, Jefferis-Kirk C, Armatage A, Kronmal RA, Salerno JC (2018) Files MD5. Development and implementation of a standardized heparin protocol for left-sided pediatric electrophysiology procedures. Pediatr Cardiol 39:941–947CrossRefGoogle Scholar
  9. 9.
    Monagle P, Chan AK, Goldengerg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, Vesely SK, American College of Chest Physicians (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e737S–e810SCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pediatric Hematology Department, Hospital Sant Joan de Déu de BarcelonaUniversitat de BarcelonaEsplugues de LlobregatSpain
  2. 2.Institut de Recerca Pediàtrica Hospital Sant Joan de Déu de Barcelona (IRP-HSJD)BarcelonaSpain
  3. 3.Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBER ER), Instituto de Salud Carlos IIIMadridSpain
  4. 4.Arrhythmia Unit, Cardiology Department, Hospital Sant Joan de DéuUniversitat de BarcelonaBarcelonaSpain

Personalised recommendations